Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for attention impairment after pediatric cancer treatment
2007-005442-20Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in confusion comparing Donepezil hydrochloride with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2008; status: completed.
02
Drugs
donepezil
03
Conditions
confusion
Beyond the preview
Go deeper on 2007-005442-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005442-20.